glp-1 microdose tirzepatide Protocol Microdosing
Description
Mounjaro is a weight loss injection manufactured by Eli Lilly that targets obesity through its dual action as both a GLP-1 and GIP agonist.
This decision raises important questions about safety, access, and the best treatment options for weight management.
Enhanced with Vitamin C and Hyaluronic Acid
Drug-free nausea relief for travel, pregnancy, GLP-1 meds, post-op & chemo
